Skip to content

Clinical trials

Phase 1 Cachexia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cachexia Phase: Phase 1 Country / region: United States Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20091
20101
20121
20142
20151
20171
20202
20212
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting1
Not yet recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Pfizer4
AVEO Pharmaceuticals, Inc.2
National Institute of Allergy and Infectious Diseases (NIAID)2
Andrew Hendifar, MD1
Dartmouth-Hitchcock Medical Center1
Endevica Bio1
M.D. Anderson Cancer Center1
The University of Texas Medical Branch, Galveston1
Tu Dan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cachexia20
Weight Loss7
Anorexia4
Carcinoma, Non-Small-Cell Lung4
Fatigue3
Neoplasms3
Pancreatic Neoplasms3
Colorectal Neoplasms2
HIV Infections2
Lung Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.